Bumetanide
RxNorm 1808
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1808 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Bumetanide.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
INPrescribable
Ingredient (IN):
Bumetanide
(Atom ID: 12253255)
PTPrescribable
Designated preferred name (PT):
Bumetanide
(Atom ID: 55611)
FNPrescribable
Full form of descriptor (FN):
Bumetanide (substance)
(Atom ID: 55626)
PTPrescribable
Designated preferred name (PT):
Bumetanide-containing product
(Atom ID: 10798414)
FNPrescribable
Full form of descriptor (FN):
Product containing bumetanide (medicinal product)
(Atom ID: 9254477)
Patient Education
Bumetanide
Bumetanide is used to treat edema (fluid retention; excess fluid held in body tissues) caused by various medical problems, including heart, kidney, and liver disease. Bumetanide is in a class of medications called diuretics ('water pills'). It works by causing the kidneys to get rid of unneeded water and salt from the body into the urine.
[Learn More]
* Please review the disclaimer below.